|
1) Gaytan F, Barreiro ML, Chopin LK, et al. Immunolocalization of ghrelin and its functional receptor, the type 1a growth hormone secre-tagogue receptor, in the cyclic human ovary. J Clin Endocrinol Metab 2003; 88: 879-87
|
|
|
|
|
2) Tropea A, Tiberi F, Minici F, et al. Ghrelin affects the release of luteolytic and luteotropic factors in human luteal cells. J Clin Endocrinol Metab. 2007; 92: 3239-45
|
|
|
|
|
3) Viani I, Vottero A, Tassi F, et al. Ghrelin inhibits steroid biosynthesis by cultured granulosa-lutein cells. J Clin Endocrinol Metab. 2008; 93: 1476-81
|
|
|
|
|
|
4) Xu J, Xu F, Hennebold JD, et al. Expression and role of the corticotropin-releasing hormone/urocortin-receptor-binding protein system in the primate corpus luteum during the menstrual cycle. Endocrinology. 2007; 148: 5385-95
|
|
|
|
|
|
5) Nicklin LT, Robinson RS, Campbell BK, et al. Leptin infusion during the early luteal phase in ewes does not affect progesterone production. Domest Anim Endocrinol. 2007; 33: 240-4
|
|
|
|
|
|
6) Tsai EM, Chan TF, Chang Y, et al. Leptin suppresses human chorionic gonadotropin-induced cyclooxygenase-2 expression and prostaglandin production in cultured human granulose luteal cells. J Soc Gynecol Investig. 2006; 13: 551-7
|
|
|
|
|
|
7) Chabrolle C, Tosca L, Dupont J. Regulation of adiponectin and its receptors in rat ovary by human chorionic gonadotrophin treatment and potential involvement of adiponectin in granulosa cell steroidogenesis. Reproduction. 2007; 133: 719-31
|
|
|
|
|
|
8) Duncan WC, van den Driesche S, Fraser HM. Inhibition of vascular endothelial growth factor in the primate ovary up-regulates hypoxia-inducible factor-1{alpha} in the follicle and corpus luteum. Endocrinology. 2008; 149: 3313-20
|
|
|
|
|
|
9) van den Driesche S, Myers M, Gay E, et al. Human chorionic gonadotrophin up-regulates hypoxia inducible factor-1 alpha in luteinising granulosa cells: implications for the hormonal regulation of vascular endothelial growth factor A in the human corpus luteum. Mol Hum Reprod. 2008; 14: 455-64
|
|
|
|
|
|
10) Robinson RS, Nicklin LT, Hammond AJ, et al. Fibroblast growth factor 2 is more dynamic than vascular endothelial growth factor A during the follicle-luteal transition in the cow. Biol Reprod. 2007; 77: 28-36
|
|
|
|
|
|
11) Yamashita H, Kamada D, Shirasuna K, et al. Effect of local neutralization of basic fibroblast growth factor or vascular endothelial growth factor by a specific antibody on the development of the corpus luteum in the cow. Mol Reprod Dev. 2008; 75: 1449-56
|
|
|
|
|
|
12) Erdmann S, Ricken A, Merkwitz C, et al. The expression of prolactin and its cathepsin D-mediated cleavage in the bovine corpus luteum vary with the estrous cycle. Am J Physiol Endocrinol Metab. 2007; 293: E1365-77
|
|
|
|
|
|
13) Lin SY, Craythorn RG, O'Connor AE, et al. Female infertility and disrupted angiogenesis are actions of specific follistatinisoforms. Mol Endocrinol. 2008; 22: 415-29
|
|
|
|
|
|
14) Sleer LS, Taylor CC. Platelet-derived growth factors and receptors in the rat corpus luteum: localization and identification of an effect on luteogenesis. Biol Reprod. 2007; 76: 391-400
|
|
|
|
|
|
15) Chen SU, Chou CH, Lee H, et al. Lysophosphat-idic acid up-regulates expression of interleukin-8 and -6 in granulosa-lutein cells through its receptors and nuclear factor-kappaB dependent pathways: implications for angiogenesis of corpus luteum and ovarian hyperstimulation syndrome. J Clin Endocrinol Metab. 2008; 93: 935-43
|
|
|
|
|
|
16) Furukawa K, Fujiwara H, Sato Y, et al. Platelets are novel regulators of neovascularization and luteinization during human corpus luteum forma-tion. Endocrinology. 2007; 148: 3056-64
|
|
|
|
|
|
17) Nurden AT. Platelets and tissue remodeling: extending the role of the blood clotting system. Endocrinology. 2007; 148: 3053-5
|
|
|
|
|
|
18) Fujiwara H, Honda T, Uea M, et al. Laminin suppresses progesterone production by human luteinizing granulosa cells via interaction with integrinα6β1. J Clin Endocrinol Metab. 1997; 82: 2122-8
|
|
|
|
|
|
19) Honda T, Fujiwara H, Yamada S, et al. Integrinα5 is expressed on human luteinizing granulosa cellsduring corpus luteum formation, and its expression is enhanced by human chorionicgonadotrophin in vitro. Mol Hum Reprod. 1997; 3: 979-84
|
|
|
|
|
|
20) Yamada S, Fujiwara H, Honda T, et al. Human granulosa cells express integrinα2 and collagen type IV: possibleinvolvement of collagen type IV in granulosa cell luteinization. Mol Hum Reprod. 1999; 5: 607-17
|
|
|
|
|
|
21) Rolaki A, Coukos G, Loutradis D, et al. Luteogenic hormones act through a vascular endothelial growth factor-dependent mechanism to up-regulateα5β1 andαvβ3 integrins, promoting the migration and survival of human luteinized granulosa cells. Am J Pathol. 2007; 170: 1561-72
|
|
|
|
|
|
22) Wahlberg P, Boden I, Paulsson J, et al. Functional corpora lutea are formed in matrix metallo-proteinase inhibitor-treated plasminogen-deficient mice. Endocrinology. 2007; 148: 1226-34
|
|
|
|
|
|
23) Gaytan M, Morales C, Sanchez-Criado JE, et al. Immunolocalization of beclin 1, a bcl-2-binding, autophagy-related protein, in the human ovary: possible relation to life span of corpus luteum. Cell Tissue Res. 2008; 331: 509-17
|
|
|
|
|
|
24) Nio J, Iwanaga T. Galectins in the mouse ovary: concomitant expression of galectin-3 and progesterone degradation enzyme (20alpha-HSD) in the corpus luteum. J Histochem Cytochem. 2007; 55: 423-32
|
|
|
|
|
|
25) Otsuka M, Zheng M, Hayashi M, et al. Impaired microRNA processing causes corpus luteum insufficiency and infertility in mice. J Clin Invest. 2008; 118: 1944-54
|
|
|
|
|